Tony Barclay joins the cancer diagnostics company.
Cancer diagnostics company Pacific Edge has announced the appointment of Tony Barclay as an independent non-executive director.
Barclay brings to the NZX and ASX-listed company experience taking New Zealand technology to international markets, including the US.
Barclay currently holds a number of roles in the medical and healthcare sector. He is an independent chair of Izon Science, chair of Australian-based Baymatob, and an independent director of Veriphi.
He was formerly chief financial officer and company secretary of Fisher & Paykel Healthcare in 2001.
Pacific Edge chair Chris Gallaher said: “Tony ... brings to the company world-class corporate finance expertise and a deep understanding of the challenges fast-growing healthcare technology companies face taking their products to the world.”
Barclay said he was looking forward to joining the Pacific Edge board, and takes up the role on March 21.
This is supplied content and not commissioned or paid for by NBR.
